FI935381A - 6,7-modifioituja paklitakseleita - Google Patents

6,7-modifioituja paklitakseleita Download PDF

Info

Publication number
FI935381A
FI935381A FI935381A FI935381A FI935381A FI 935381 A FI935381 A FI 935381A FI 935381 A FI935381 A FI 935381A FI 935381 A FI935381 A FI 935381A FI 935381 A FI935381 A FI 935381A
Authority
FI
Finland
Prior art keywords
alkyl
formula
alkynyl
cycloalkyl
alkenyl
Prior art date
Application number
FI935381A
Other languages
English (en)
Swedish (sv)
Other versions
FI935381A0 (fi
FI109795B (fi
Inventor
Shu-Hui Chen
Vittorio Farina
Gregory Roth
John Kadow
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/128,619 external-priority patent/US5380751A/en
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of FI935381A0 publication Critical patent/FI935381A0/fi
Publication of FI935381A publication Critical patent/FI935381A/fi
Application granted granted Critical
Publication of FI109795B publication Critical patent/FI109795B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FI935381A 1992-12-04 1993-12-01 Menetelmä terapeuttisesti käyttökelpoisten 6,7-modifioitujen paklitakseleiden valmistamiseksi FI109795B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US98576192A 1992-12-04 1992-12-04
US98576192 1992-12-04
US08/128,619 US5380751A (en) 1992-12-04 1993-09-28 6,7-modified paclitaxels
US12861993 1993-09-28

Publications (3)

Publication Number Publication Date
FI935381A0 FI935381A0 (fi) 1993-12-01
FI935381A true FI935381A (fi) 1994-06-05
FI109795B FI109795B (fi) 2002-10-15

Family

ID=26826766

Family Applications (1)

Application Number Title Priority Date Filing Date
FI935381A FI109795B (fi) 1992-12-04 1993-12-01 Menetelmä terapeuttisesti käyttökelpoisten 6,7-modifioitujen paklitakseleiden valmistamiseksi

Country Status (20)

Country Link
EP (1) EP0600517B1 (fi)
JP (1) JP3360186B2 (fi)
CN (1) CN1049433C (fi)
AT (1) ATE195939T1 (fi)
AU (1) AU668777B2 (fi)
CA (1) CA2109861C (fi)
CZ (1) CZ287599B6 (fi)
DE (1) DE69329327T2 (fi)
DK (1) DK0600517T3 (fi)
ES (1) ES2149188T3 (fi)
FI (1) FI109795B (fi)
GR (1) GR3034686T3 (fi)
HU (2) HU221817B1 (fi)
IL (1) IL107819A (fi)
MX (1) MX9307555A (fi)
NO (1) NO305756B1 (fi)
NZ (1) NZ250343A (fi)
PL (1) PL178135B1 (fi)
PT (1) PT600517E (fi)
SG (1) SG55014A1 (fi)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998656A (en) * 1991-09-23 1999-12-07 Florida State University C10 tricyclic taxanes
IL107950A (en) 1992-12-15 2001-04-30 Upjohn Co b 7, b 8 - Matano - Taxols, their preparation and pharmaceutical preparations against malignant tumors containing them
IL108316A (en) * 1993-01-15 2006-10-31 Univ Florida State History of C-10 Texan and pharmaceuticals containing them
ATE264316T1 (de) * 1993-06-11 2004-04-15 Upjohn Co Delta 6,7-taxol derivate antineoplastische verwendung und diese enthaltende pharmazeutische zusammenstellungen
IL127598A (en) * 1994-01-28 2003-04-10 Upjohn Co Process for preparing isotaxol analogs
US5395850A (en) * 1994-03-10 1995-03-07 Bristol-Myers Squibb Company 6,7-epoxy paclitaxels
GB9409131D0 (en) * 1994-05-09 1994-06-29 Erba Carlo Spa Unsaturated taxane compounds
FR2721025B1 (fr) * 1994-06-09 1996-07-12 Rhone Poulenc Rorer Sa Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
FR2721026B1 (fr) * 1994-06-09 1996-07-12 Rhone Poulenc Rorer Sa Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
US5840929A (en) * 1995-04-14 1998-11-24 Bristol-Myers Squibb Company C4 methoxy ether derivatives of paclitaxel
FR2742753B1 (fr) * 1995-12-22 1998-01-30 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
US5773461A (en) * 1996-06-06 1998-06-30 Bristol-Myers Squibb Company 7-deoxy-6-substituted paclitaxels
US5635531A (en) * 1996-07-08 1997-06-03 Bristol-Myers Squibb Company 3'-aminocarbonyloxy paclitaxels
US5773464A (en) * 1996-09-30 1998-06-30 Bristol-Myers Squibb Company C-10 epoxy taxanes
US5977386A (en) * 1996-12-24 1999-11-02 Bristol-Myers Squibb Company 6-thio-substituted paclitaxels
US5902822A (en) * 1997-02-28 1999-05-11 Bristol-Myers Squibb Company 7-methylthiooxomethyl and 7-methylthiodioxomethyl paclitaxels
US5912264A (en) * 1997-03-03 1999-06-15 Bristol-Myers Squibb Company 6-halo-or nitrate-substituted paclitaxels
US6017935A (en) * 1997-04-24 2000-01-25 Bristol-Myers Squibb Company 7-sulfur substituted paclitaxels
IT1317731B1 (it) * 2000-01-18 2003-07-15 Indena Spa Tassani semisintetici con attivita' antitumorale ed antiangiogenetica.
ATE392422T1 (de) 2000-02-02 2008-05-15 Univ Florida State Res Found C7-carbamoyloxysubstituierte taxane als antitumormittel
JP2003522171A (ja) 2000-02-02 2003-07-22 フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド 抗腫瘍剤としてのc10カーボネート置換タキサン
US6649632B2 (en) 2000-02-02 2003-11-18 Fsu Research Foundation, Inc. C10 ester substituted taxanes
WO2001057033A1 (en) 2000-02-02 2001-08-09 Florida State University Research Foundation, Inc. C10 carbamoyloxy substituted taxanes as antitumor agents
ES2372321T3 (es) 2001-06-20 2012-01-18 Genentech, Inc. Composiciones y métodos para el diagnóstico y tratamiento de un tumor de pulmón.
KR101008758B1 (ko) 2001-09-18 2011-01-14 제넨테크, 인크. 종양의 진단 및 치료를 위한 방법 및 이를 위한 조성물
KR100623128B1 (ko) 2002-01-02 2006-09-14 제넨테크, 인크. 종양의 진단 및 치료 방법 및 이를 위한 조성물
EP2011886A3 (en) 2002-04-16 2009-02-11 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
AU2003243400B2 (en) 2002-06-07 2009-10-29 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
ES2472690T3 (es) 2003-11-17 2014-07-02 Genentech, Inc. Anticuerpo contra CD22 para el tratamiento de tumores de origen hematopoy�tico
PE20050693A1 (es) 2004-02-13 2005-09-27 Univ Florida State Res Found Taxanos sustituidos con esteres de ciclopentilo en c10
GT200500025A (es) * 2004-02-13 2005-09-30 Taxanos sustituidos con esteres de ciclopentilo en c10
DE602006013275D1 (de) 2005-01-07 2010-05-12 Diadexus Inc Ovr110-antikörperzusammensetzungen und verwendungsverfahren dafür
WO2007126455A2 (en) 2006-04-05 2007-11-08 Genentech, Inc. Method for using boc/cdo to modulate hedgehog signaling
CA2670696A1 (en) 2006-11-27 2008-06-05 Diadexus, Inc. Ovr110 antibody compositions and methods of use
ES2379413T3 (es) 2007-02-22 2012-04-25 Genentech, Inc. Procedimientos para detectar la enfermedad inflamatoria del intestino
JP2010533495A (ja) 2007-07-16 2010-10-28 ジェネンテック, インコーポレイテッド ヒト化CD79b抗体およびイムノコンジュゲートならびにそれらの使用
PT2176296E (pt) 2007-07-16 2012-05-14 Genentech Inc Anticorpos e imunoconjugados anti-cd79b e métodos de utilização
MY157403A (en) 2008-01-31 2016-06-15 Genentech Inc Anti-cd79b antibodies and immunoconjugates and methods of use
WO2009145981A1 (en) 2008-03-31 2009-12-03 Florida State University Research Foundation, Inc. C(10) ethyl ester and c(10) cyclopropyl ester substituted taxanes
JP6132548B2 (ja) 2009-04-01 2017-05-24 ジェネンテック, インコーポレイテッド 抗FcRH5抗体および免疫接合体および使用方法
ES2564207T3 (es) 2009-10-22 2016-03-18 F. Hoffmann-La Roche Ag Métodos y composiciones para modular la activación con hepsina de la proteína estimuladora de macrófagos
EP3002297B1 (en) 2009-11-30 2020-04-08 F. Hoffmann-La Roche AG Antibodies for treating and diagnosing tumors expressing slc34a2 (tat211)
KR20130004579A (ko) 2010-02-23 2013-01-11 제넨테크, 인크. 종양의 진단 및 치료를 위한 조성물 및 방법
RU2636461C2 (ru) 2010-05-03 2017-11-23 Дженентек, Инк. Композиции и способы для диагностики и лечения опухоли
CN104650012A (zh) * 2013-11-22 2015-05-27 天士力控股集团有限公司 一种紫杉烷类化合物
WO2015116902A1 (en) 2014-01-31 2015-08-06 Genentech, Inc. G-protein coupled receptors in hedgehog signaling
CN112040981A (zh) 2018-04-13 2020-12-04 基因泰克公司 稳定的抗cd79b免疫缀合物制剂

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
US4876399A (en) * 1987-11-02 1989-10-24 Research Corporation Technologies, Inc. Taxols, their preparation and intermediates thereof
US5175315A (en) * 1989-05-31 1992-12-29 Florida State University Method for preparation of taxol using β-lactam
US5015744A (en) * 1989-11-14 1991-05-14 Florida State University Method for preparation of taxol using an oxazinone
MX9102128A (es) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
US5227400A (en) * 1991-09-23 1993-07-13 Florida State University Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them
US5272171A (en) * 1992-02-13 1993-12-21 Bristol-Myers Squibb Company Phosphonooxy and carbonate derivatives of taxol
ATE264316T1 (de) * 1993-06-11 2004-04-15 Upjohn Co Delta 6,7-taxol derivate antineoplastische verwendung und diese enthaltende pharmazeutische zusammenstellungen

Also Published As

Publication number Publication date
DE69329327D1 (de) 2000-10-05
CZ260393A3 (en) 1994-07-13
FI935381A0 (fi) 1993-12-01
EP0600517B1 (en) 2000-08-30
HU221817B1 (hu) 2003-01-28
PL178135B1 (pl) 2000-03-31
CN1049433C (zh) 2000-02-16
CZ287599B6 (en) 2001-01-17
CA2109861A1 (en) 1994-06-05
PL301305A1 (en) 1994-06-13
CA2109861C (en) 1999-03-16
JPH06211823A (ja) 1994-08-02
DK0600517T3 (da) 2000-10-30
AU5212193A (en) 1994-06-16
ES2149188T3 (es) 2000-11-01
CN1094041A (zh) 1994-10-26
MX9307555A (es) 1995-01-31
PT600517E (pt) 2000-12-29
HU222347B1 (hu) 2003-06-28
NZ250343A (fi) 1996-11-26
IL107819A0 (en) 1994-04-12
HU9303428D0 (en) 1994-04-28
AU668777B2 (en) 1996-05-16
NO934277D0 (no) 1993-11-26
NO305756B1 (no) 1999-07-19
FI109795B (fi) 2002-10-15
ATE195939T1 (de) 2000-09-15
JP3360186B2 (ja) 2002-12-24
NO934277L (no) 1994-06-06
GR3034686T3 (en) 2001-01-31
SG55014A1 (en) 1998-12-21
IL107819A (en) 2000-06-29
EP0600517A1 (en) 1994-06-08
DE69329327T2 (de) 2001-04-05
HUT65640A (en) 1994-07-28

Similar Documents

Publication Publication Date Title
DK0600517T3 (da) 6,7-modificerede paclitaxeler.
DE69331892D1 (de) Desoxy-Taxol-Derivate
PL299513A1 (en) Fluorotaxoles

Legal Events

Date Code Title Description
MA Patent expired